Catalyst Wire Dossier Catalyst Wire Dossier

DEBIRI (irinotecan-eluting beads)

irinotecan-eluting beads
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DEBIRI (irinotecan-eluting beads), covering 2017-02-14 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases [Phase 3]

See pricing